Located on Chromosome 17, this mutation impacts GH-LCR, SCN4A (growth hormone locus control region| sodium voltage-gated channel alpha subunit 4). What is its biological consequence — is it benign or pathogenic, and which disease is associated if any?
Pathogenic; Hyperkalemic periodic paralysis